These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 3325197)

  • 1. A study of beta-cell function after glucagon stimulation in thalassaemia major treated by high transfusion programme.
    Livadas DP; Economou E; Sofroniadou K; Fotiadou-Pappa H; Van Melle GD; Temler E; Felber JP
    Clin Endocrinol (Oxf); 1987 Oct; 27(4):485-90. PubMed ID: 3325197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study of A- and B-cell function in beta-thalassemia major.
    Maioli M; Pacifico A; Frulio T; Longinotti M
    Acta Diabetol Lat; 1983; 20(2):143-52. PubMed ID: 6349202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alpha and beta cell evaluation in patients with thalassaemia intermedia and iron overload.
    De Sanctis V; Gamberini MR; Borgatti L; Atti G; Vullo C; Bagni B
    Postgrad Med J; 1985 Nov; 61(721):963-7. PubMed ID: 3906615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta-cell function assessed by plasma C-peptide evaluation in diabetic thalassaemic patients.
    Atti G; Capra L; De Sanctis V; Vullo C; Bagni B
    Helv Paediatr Acta; 1983 May; 38(2):123-32. PubMed ID: 6347976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carbohydrate metabolism and pancreatic islet-cell function in thalassemia major.
    Costin G; Kogut MD; Hyman C; Ortega JA
    Diabetes; 1977 Mar; 26(3):230-40. PubMed ID: 320076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered C-peptide/insulin molar ratios and glucose turnover rates after stimulation in nondiabetic offsprings of type II diabetic patients.
    Osei K; Holland GC
    Metabolism; 1987 Feb; 36(2):122-7. PubMed ID: 3543613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Basal and glucagon-stimulated plasma C-peptide concentrations in healthy dogs, dogs with diabetes mellitus, and dogs with hyperadrenocorticism.
    Montgomery TM; Nelson RW; Feldman EC; Robertson K; Polonsky KS
    J Vet Intern Med; 1996; 10(3):116-22. PubMed ID: 8743209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pancreatic alpha-cell function in diabetic hemochromatotic subjects.
    Nelson RL; Baldus WP; Rubenstein AH; Go VL; Service FJ
    J Clin Endocrinol Metab; 1979 Sep; 49(3):412-6. PubMed ID: 381322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Beta-pancreatic function in subjects with thalassemia. A 4-year follow-up].
    Zanini R; Briante G; Cantone P; Sticca M; Grasso U
    Pediatr Med Chir; 1985; 7(5):749-53. PubMed ID: 3915549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C-peptide response to glucagon in young diabetics.
    Juang JH; Huang BY; Huang HS; Lin JD; Huang MJ
    Taiwan Yi Xue Hui Za Zhi; 1989 Jun; 88(6):579-83. PubMed ID: 2677232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlations between fasting plasma C-peptide, glucagon-stimulated plasma C-peptide, and urinary C-peptide in insulin-treated diabetics.
    Gjessing HJ; Matzen LE; Frøland A; Faber OK
    Diabetes Care; 1987; 10(4):487-90. PubMed ID: 3304899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pancreatic beta-cell function in cirrhotic patients with and without overt diabetes. C-peptide response to glucagon and to meal.
    Marchesini G; Melli A; Checchia GA; Mattioli L; Capelli M; Cassarani S; Zoli M; Pisi E
    Metabolism; 1985 Aug; 34(8):695-701. PubMed ID: 3894876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of insulin secretion based on changes in plasma insulin and C-peptide in man.
    Sakai T; Ohneda A; Nihei J; Kobayashi T
    Tohoku J Exp Med; 1982 Dec; 138(4):427-40. PubMed ID: 6761899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin and C-peptide in ascitic fluid and plasma and their relative responses to glucagon in patients with cirrhosis.
    Akgün S; Samanta A; Ertel NH
    J Endocrinol Invest; 1988 Dec; 11(11):789-93. PubMed ID: 3066813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of alpha and beta cells in the impaired glucose tolerance of thalassaemic subjects.
    Passariello N; Paolisso G; Sgambato S; D'Onofrio F
    Diabete Metab; 1987; 13(4):436-40. PubMed ID: 3315764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reproducibility of beta-cell function estimates in non-insulin-dependent diabetes mellitus.
    Gjessing HJ; Damsgaard EM; Matzen LE; Frøland A; Faber OK
    Diabetes Care; 1987; 10(5):558-62. PubMed ID: 3315512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C-peptide response to glucagon. A test for the residual beta-cell function in diabetes mellitus.
    Faber OK; Binder C
    Diabetes; 1977 Jul; 26(7):605-10. PubMed ID: 326604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Islet hormonal regulation of glucose turnover during exercise in type 1 diabetes.
    Shilo S; Sotsky M; Shamoon H
    J Clin Endocrinol Metab; 1990 Jan; 70(1):162-72. PubMed ID: 1967178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physiological and pharmacological stimulation of pancreatic islet hormone secretion in type I diabetic pancreas allograft recipients.
    Osei K; Henry ML; O'Dorisio TM; Tesi RJ; Sommer BG; Ferguson RM
    Diabetes; 1990 Oct; 39(10):1235-42. PubMed ID: 2210076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Relationship between fasting glycemia, serum peptide C, insulin, growth hormone and plasma glucagon in acromegaly].
    Piniewska-Hułas D; Lewandowski Z; Kasperska-Dworak A; Bonicki W
    Pol Arch Med Wewn; 1996 Jun; 95(6):524-33. PubMed ID: 9005421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.